531 related articles for article (PubMed ID: 25278909)
1. Dopamine and glucose, obesity, and reward deficiency syndrome.
Blum K; Thanos PK; Gold MS
Front Psychol; 2014; 5():919. PubMed ID: 25278909
[TBL] [Abstract][Full Text] [Related]
2. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
[TBL] [Abstract][Full Text] [Related]
3. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
4. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
Blum K; Baron D; McLaughlin T; Gold MS
J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
[TBL] [Abstract][Full Text] [Related]
5. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
[TBL] [Abstract][Full Text] [Related]
6. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
[TBL] [Abstract][Full Text] [Related]
7. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
[TBL] [Abstract][Full Text] [Related]
9. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.
Blum K; Thanos PK; Oscar-Berman M; Febo M; Baron D; Badgaiyan RD; Gardner E; Demetrovics Z; Fahlke C; Haberstick BC; Dushaj K; Gold MS
J Reward Defic Syndr; 2015; 1(3):95-104. PubMed ID: 27398406
[TBL] [Abstract][Full Text] [Related]
10. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
11. Reward circuitry dopaminergic activation regulates food and drug craving behavior.
Blum K; Liu Y; Shriner R; Gold MS
Curr Pharm Des; 2011; 17(12):1158-67. PubMed ID: 21492092
[TBL] [Abstract][Full Text] [Related]
12. Imaging of brain dopamine pathways: implications for understanding obesity.
Wang GJ; Volkow ND; Thanos PK; Fowler JS
J Addict Med; 2009 Mar; 3(1):8-18. PubMed ID: 21603099
[TBL] [Abstract][Full Text] [Related]
13. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
[TBL] [Abstract][Full Text] [Related]
14. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.
Blum K; Bailey J; Gonzalez AM; Oscar-Berman M; Liu Y; Giordano J; Braverman E; Gold M
J Genet Syndr Gene Ther; 2011 Dec; 2012(1):. PubMed ID: 23483116
[TBL] [Abstract][Full Text] [Related]
15. Dopamine signaling in food addiction: role of dopamine D2 receptors.
Baik JH
BMB Rep; 2013 Nov; 46(11):519-26. PubMed ID: 24238362
[TBL] [Abstract][Full Text] [Related]
16. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
17. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.
Blum K; Badgaiyan RD; Agan G; Fratantonio J; Simpatico T; Febo M; Haberstick BC; Smolen A; Gold MS
J Reward Defic Syndr; 2015; 1(1):65-68. PubMed ID: 26052557
[TBL] [Abstract][Full Text] [Related]
18. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
[TBL] [Abstract][Full Text] [Related]
19. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
[TBL] [Abstract][Full Text] [Related]
20. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors.
Bello EP; Mateo Y; Gelman DM; Noaín D; Shin JH; Low MJ; Alvarez VA; Lovinger DM; Rubinstein M
Nat Neurosci; 2011 Jul; 14(8):1033-8. PubMed ID: 21743470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
